| Application no. and date | 13002793.1 (espacenet) (Federated) (European Patent Register), 20090602 | | Patent/reg. no. and date | DK/EP 2650008, 20141217 | | Publication date | 20131016 | | Priority no. and date | WO PCT/EP2008/004341, 20080530 | | EP pub. no. and date |
EP 2650008 20131016 | | Effective date | | | Applicant/owner | Xigen Inflammation Ltd., Arch. Makariou III
195 Neocleous House
3030 Limassol, CY | | Applicant ref. no. | 158632 | | Inventor | Bonny, Christophe, En Vernaules
1580 Avenches, CH | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 38/01 (2006.01) , A61K 38/03 (2006.01) , A61K 38/04 (2006.01) , A61P 11/00 (2006.01) , A61P 17/00 (2006.01) , A61P 25/00 (2006.01) , A61P 31/12 (2006.01) , A61P 37/00 (2006.01) , A61P 9/00 (2006.01) | | Title | Anvendelse af cellepermeable peptidinhibitorer af JNK-signaltransduktionsvejen til behandlingen af forskellige cancersygdomme | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
